Migraine
Trigeminal Autonomic Cephalalgias
Migraine Headaches
Professional Guidelines
Diagnosis
Classification
Vistagen announces new patents for investigational pherine nasal spray to treat migraine
A clinical-stage neuroscience-focused biopharmaceutical company has received new international patents related to an investigational neuroactive pherine nasal spray to potentially treat individuals with migraine.
More triptan use linked to more acute treatment, hospital visits, health care costs
SAN DIEGO — Patients who used two or more triptans for migraine faced more acute treatment, more emergency-related hospital visits and higher medical costs compared with those who used one, data show.
Dihydroergotamine led to significant headache pain reduction at 48 hours, up to 12 months
SAN DIEGO — Treating migraine with a novel formulation of dihydroergotamine powder was linked to favorable outcomes including significant headache pain reduction at 48 hours post dose that was extended to 12 months.
Gepants provide benefit as preventive treatment for headache in young people
SAN DIEGO — In a small cohort of young people, use of gepants to treat headache led to some therapeutic benefit and led to few adverse events, according to a poster from the American Headache Society Annual Scientific Meeting.
Wearable remote electrical neuromodulation device improves outcomes in migraine
SAN DIEGO — A wearable remote electrical neuromodulation device provided consistent efficacy and clinically meaningful benefit to those with migraine, according to a poster presentation at the American Headache Society Annual Scientific Meeting.